Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure
Although the introduction of immunotherapy has tremendously improved the prognosis of patients with metastatic cancers of different histological origins, some tumors fail to respond or develop resistance. Broadening the clinical efficacy of currently available immunotherapy strategies requires an im...
Main Authors: | Lorenzo Castagnoli, Francesca De Santis, Tatiana Volpari, Claudio Vernieri, Elda Tagliabue, Massimo Di Di Nicola, Serenella M Pupa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/555 |
Similar Items
-
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
by: Cai Zhang, et al.
Published: (2020-06-01) -
Tumor microenvironment and immunotherapy of oral cancer
by: Chang Liu, et al.
Published: (2022-10-01) -
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
by: Fei Li, et al.
Published: (2024-01-01) -
Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
by: Ye Xiong, et al.
Published: (2022-09-01) -
Cancer immunotherapies: advances and bottlenecks
by: Rui Rui, et al.
Published: (2023-08-01)